Illumina, Inc.ILMN

NasdaqHealthcareLaboratory Analytical Instruments
Price (close)
$273.90
Market cap
$41.9B
P/E
50.8x
Revenue (TTM)
$4.5B
Net income
$825.0M
Dividend yield
—
1-year total return
197.1%
Net margin
18.4%
Revenue growth
4.9%
Debt / equity
0.53x

What Illumina, Inc. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$3.2B$4.5B$4.6B$4.5B$4.4B$4.3B
Net income$656.0M$762.0M-$4.4B-$1.2B-$1.2B$850.0M
Free cash flow$891.0M$337.0M$106.0M$283.0M$709.0M$931.0M

More on ILMN.

Figures from Illumina, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.